1. Home
  2. FCCO vs ENTA Comparison

FCCO vs ENTA Comparison

Compare FCCO & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Community Corporation

FCCO

First Community Corporation

N/A

Current Price

$33.76

Market Cap

320.5M

Sector

Finance

ML Signal

N/A

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

N/A

Current Price

$12.58

Market Cap

377.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FCCO
ENTA
Founded
1994
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
320.5M
377.5M
IPO Year
2012
2012

Fundamental Metrics

Financial Performance
Metric
FCCO
ENTA
Price
$33.76
$12.58
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$20.40
AVG Volume (30 Days)
39.2K
231.6K
Earning Date
04-22-2026
05-11-2026
Dividend Yield
2.16%
N/A
EPS Growth
36.46
29.93
EPS
1.39
N/A
Revenue
$922,000.00
$102,814,000.00
Revenue This Year
$30.67
$7.76
Revenue Next Year
$5.87
N/A
P/E Ratio
$24.32
N/A
Revenue Growth
N/A
16.48
52 Week Low
$25.92
$7.05
52 Week High
$35.74
$17.15

Technical Indicators

Market Signals
Indicator
FCCO
ENTA
Relative Strength Index (RSI) 55.00 45.20
Support Level $32.44 $12.19
Resistance Level $35.45 $14.03
Average True Range (ATR) 0.79 0.54
MACD 0.03 -0.13
Stochastic Oscillator 69.66 32.86

Price Performance

Historical Comparison
FCCO
ENTA

About FCCO First Community Corporation

First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are: Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: